Institution · Centre d'Étude des Pathologies Respiratoires

Most cited papers from Centre d'Étude des Pathologies Respiratoires

Centre d'Étude des Pathologies Respiratoires

What are the most cited papers from Centre d'Étude des Pathologies Respiratoires?

The most cited paper from Centre d'Étude des Pathologies Respiratoires is "Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm" (Jean-Baptiste Lascarrou et al., 2019), with 669 citations. Next come "Pulmonary manifestations of Sjögren's syndrome" (328) and "Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model" (249).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 44 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm Jean-Baptiste Lascarrou et al. · New England Journal of Medicine Open access	2 Oct 2019	669
2	Pulmonary manifestations of Sjögren's syndrome Thomas Flament, Adrien Bigot, Benjamin Chaigne et al. · European Respiratory Review Open access	31 May 2016	328
3	Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model Laura Brullé, Marc Vandamme, Delphine Riès et al. · PLoS ONE Open access	26 Dec 2012	249
4	Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity Héloïse Flament et al. · Nature Immunology Open access	2 Feb 2021	215
5	Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients Youenn Jouan, Antoine Guillon, Loïc Gonzalez et al. · The Journal of Experimental Medicine Open access	13 Aug 2020	191
6	Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial J. P. Frat et al. · The Lancet Respiratory Medicine Open access	18 Mar 2019	189
7	Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR Denis A. Mogilenko et al. · Cell Open access	25 Apr 2019	177
8	Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France Dima El Safadi et al. · BMC Infectious Diseases Open access	26 Aug 2016	152
9	Blood pressure monitoring during arrhythmia: agreement between automated brachial cuff and intra-arterial measurements Karim Lakhal, Stéphan Ehrmann, M. Martin et al. · British Journal of Anaesthesia Open access	18 Sep 2015	143
10	Nebulization as a delivery method for mAbs in respiratory diseases Renaud Respaud, Laurent Vecellio, P. Diot et al. · Expert Opinion on Drug Delivery	5 Jan 2015	142
11	Therapeutic targeting of cathepsin C: from pathophysiology to treatment Brice Korkmaz, George H. Caughey, Iain Chapple et al. · Pharmacology & Therapeutics Open access	26 May 2018	140
12	Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial Christophe Guitton, Stéphan Ehrmann, Christelle Volteau et al. · Intensive Care Medicine Open access	21 Jan 2019	136
13	Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial Julie Mankikian et al. · European Respiratory Journal Open access	25 May 2023	129
14	The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis Grégoire Savary et al. · American Journal of Respiratory and Critical Care Medicine	9 Apr 2019	115
15	Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations Olivier Le Rouzic, Muriel Pichavant, Émilie Fréalle et al. · European Respiratory Journal Open access	Oct 2017	115
16	Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system Laurent Guilleminault, Nicolas Azzopardi, Christophe Arnoult et al. · Journal of Controlled Release Open access	16 Oct 2014	114
17	Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018) Stéphane Bretagne et al. · mBio Open access152 authors	2 May 2022	108
18	The kallikrein-related peptidase family: Dysregulation and functions during cancer progression Thomas Kryza, Lakmali Munasinghage Silva, Daniela Loessner et al. · Biochimie	4 Sep 2015	105
19	Ovalbumin-related Protein X Is a Heparin-binding Ov-Serpin Exhibiting Antimicrobial Activities Sophie Réhault‐Godbert, Valérie Labas, Emmanuelle Helloin et al. · Journal of Biological Chemistry Open access	25 Apr 2013	97
20	Nasal high flow nebulization in infants and toddlers: An in vitro and in vivo scintigraphic study François Réminiac, Laurent Vecellio, Ronan Mac Loughlin et al. · Pediatric Pulmonology	8 Jul 2016	93
21	Is real-time PCR-based diagnosis similar in performance to routine parasitological examination for the identification of Giardia intestinalis , Cryptosporidium parvum / Cryptosporidium hominis and Entamoeba histolytica from stool samples? Evaluation of a new commercial multiplex PCR assay and literature review Adrien Laude, Stéphane Valot, Guillaume Désoubeaux et al. · Clinical Microbiology and Infection Open access	6 Nov 2015	92
22	GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions Sonia Brun et al. · Autophagy Open access	5 Nov 2021	91
23	Effect of formulation on the stability and aerosol performance of a nebulized antibody Renaud Respaud, Denis Marchand, Christelle Parent et al. · mAbs Open access	14 Jul 2014	88
24	Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines Vincent Cottin et al. · European Respiratory Review Open access	31 May 2014	86
25	Aerosol delivery during invasive mechanical ventilation: a systematic review Jonathan Dugernier, Stéphan Ehrmann, Thierry M. Sottiaux et al. · Critical Care ReviewOpen access	21 Oct 2017	79
26	Binding of Chondroitin 4-Sulfate to Cathepsin S Regulates Its Enzymatic Activity Juliette Sage, Florian Mallèvre, Fabien Barbarin-Costes et al. · Biochemistry	22 Aug 2013	77
27	High Dimensional Single-Cell Analysis Reveals iNKT Cell Developmental Trajectories and Effector Fate Decision Thomas Baranek, Kévin Lebrigand, Carolina de Amat Herbozo et al. · Cell Reports Open access	Sep 2020	74
28	Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases Yveline Hamon, Monika Łęgowska, Virginie Hervé et al. · Journal of Biological Chemistry Open access	17 Feb 2016	71
29	Alternative Routes of Administration for Therapeutic Antibodies—State of the Art Aubin Pitiot, Nathalie Heuzé‐Vourc'h, Thomas Sécher · Antibodies Open access	26 Aug 2022	70
30	Innovative preclinical models for pulmonary drug delivery research Stéphan Ehrmann, Otmar Schmid, Chantal Darquenne et al. · Expert Opinion on Drug Delivery Open access	14 Feb 2020	70
31	Protean proteases: at the cutting edge of lung diseases Clifford C. Taggart, Marcus Alexander Mall, Gilles Lalmanach et al. · European Respiratory Journal Open access	Feb 2017	67
32	Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin Renaud Respaud, Denis Marchand, Thibaut Pelat et al. · Journal of Controlled Release	9 May 2016	67
33	Antimicrobial proteins and peptides in human lung diseases: A friend and foe partnership with host proteases Fabien Lecaille, Gilles Lalmanach, Pierre-Marie Andrault · Biochimie	2 Sep 2015	67
34	Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation Frédéric Schlemmer, Sylvie Chevret, Gwenaël Lorillon et al. · Respiratory Medicine Open access	16 Sep 2014	66
35	Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein Antoine Guillon et al. · The EMBO Journal Open access	4 May 2022	59
36	Cathepsin V: Molecular characteristics and significance in health and disease Fabien Lecaille, Thibault Chazeirat, Ahlame Saidi et al. · Molecular Aspects of Medicine Open access	16 Mar 2022	59
37	Hiatal hernia on thoracic computed tomography in pulmonary fibrosis Céline Tossier, Clairelyne Dupin, Laurent Plantier et al. · European Respiratory Journal Open access	12 May 2016	59
38	Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections François Trottein, Christophe A. Paget · Frontiers in Immunology Open access	2 Aug 2018	58
39	Caspase-1-driven neutrophil pyroptosis and its role in host susceptibility to Pseudomonas aeruginosa Karin Santoni et al. · PLoS Pathogens Open access	18 Jul 2022	57
40	Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care Stéphan Ehrmann, Jean E. Chastre, P. Diot et al. · Annals of Intensive Care Open access	2017	57
41	Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis) Brice Korkmaz, Adam Lesner, Stéphanie Letast et al. · Seminars in Immunopathology Open access	5 Feb 2013	56
42	Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L Pierre-Marie Andrault, Sergey A. Samsonov, Günther Weber et al. · Biochemistry	17 Apr 2015	55
43	The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients Konstantinos Mavridis, Fabien Gueugnon, A Petit et al. · British Journal of Cancer Open access	31 Mar 2015	54
44	Real-life inhaler adherence and technique: Time to get smarter! Henry Chrystyn, Raphaele Audibert, Manfred Keller et al. · Respiratory Medicine Open access	12 Sep 2019	53
45	Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism Franck Patin, Philippe Corcia, Patrick Vourc’h et al. · Molecular Neurobiology	2 Sep 2016	53
46	Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study Marion Ferreira, Raphaël Borie, Bruno Crestani et al. · Respiratory Medicine Open access	9 Sep 2020	52
47	Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections Elsa Bodier‐Montagutelli, Eric Morello, Guillaume L’Hostis et al. · Expert Opinion on Drug Delivery	25 Oct 2016	51
48	Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis Emilie Dalloneau, Nadine Baroukh, Konstantinos Mavridis et al. · Oncotarget Open access	15 Jun 2016	51
49	Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L Ahlame Saidi, Mariana Kasabova, Lise Vanderlynden et al. · Scientific Reports Open access	24 Jan 2019	50
50	Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases Gilles Lalmanach, Ahlame Saidi, Sylvain Marchand-Adam et al. · Biological Chemistry	28 Aug 2014	50

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.